ECOG-ACRIN Cancer Research Group
@eaonc
Followers
6K
Following
4K
Media
4K
Statuses
8K
Biomarker-driven medical research involving adults who have or are at risk of developing cancer
1400+ member research sites
Joined November 2013
We congratulate @DrTonyLetai on his appointment as @theNCI Director. His deep scientific expertise & reputation as a collaborative leader make him an excellent choice to drive progress against #cancer. We look forward to working with him! #CancerResearch #ClinicalTrials
0
2
3
Patients with aggressive B-cell #Lymphoma that has recurred or is resistant to treatment may be eligible to participate in #ClinicalTrial EA4231. Learn more here: https://t.co/hfbZzO89Q7 cc: @MelanicjMD, @theNCI, @UVACancerCenter
0
0
1
#Clinicaltrial EA8192 aims to find out if treatment with durvalumab and chemotherapy can improve outcomes for patients with high grade upper tract #urothelialcancer prior to nephroureterectomy. https://t.co/4dphxuN1s4
#blcsm #bladdercancer cc: @JCensits, @PGrivasMDPhD
0
0
0
Do you have advanced #cancer has become worse following treatment, or advanced cancer for which no standard treatment exists? If so, you may be able to join the #ComboMATCH #PrecisionMedicine study. Learn more: https://t.co/00rdMtEMUk
0
0
0
ComboMATCH/EAY191-E5 tests how well #sotorasib with or without #panitumumab can treat patients with advanced #SolidTumors. For more information: https://t.co/sGcKIHVVD9 cc: @kspencer725, @DocDustyD #PrecisionMedicine
0
2
0
#ClinicalTrial EA7211/STRASS 2, led in the US by @kencardonaMD, is the second randomized study ever performed in retroperitoneal soft tissue #sarcoma & is enrolling patients in the US, Europe, Canada, Australia, New Zealand, & Japan! Learn more: https://t.co/vMkhLxk8Qy
0
0
0
The @cancergenomics_ clinical study (EAQ211) is evaluating the impact of social and genetic factors on outcomes in adolescent & young adult (#AYA) #cancer survivors. Learn more: https://t.co/cNXXBqqvJ4
#AYACancer #AYACSM
0
0
0
#ClinicalTrial EAA173/DETER-SMM, led by @nsc_natalie of @UWCarbone, is a randomized phase 3 trial for patients with smoldering #MultipleMyeloma (#SMM) and high-risk features. Learn more here: https://t.co/4l7zZqiy2W
#mmsm #BloodCancer
0
0
0
Do you have #AcuteMyeloidLeukemia (#AML) and are age 60 or older? If so, you may be able to participate in this study of a potential new treatment. Learn more: https://t.co/lqKwON7qZ1
#leukemia #leusm
0
0
0
Do you have newly diagnosed #Glioblastoma? If so, you may be able to participate in this study of a new treatment approach. Learn more about EAF223/GABLE here: https://t.co/NJBtg6CQfJ
0
0
0
Open and enrolling @OHSUKnight
In #ClinicalTrial EA2222/PUMP, investigators are testing #PumpChemo in addition to SOC chemo versus SOC chemo alone for patients with unresectable #ColorectalCancer liver metastases. For more: https://t.co/xBChV6GALe cc: @michael_lidsky
0
1
8
The EA5221/ACHIEVE clinical study is testing two different treatment approaches for older adults with advanced non-small cell #LungCancer. Learn more: https://t.co/4iFs1j4lU7
#NSCLC #LCSM
0
0
0
In #ClinicalTrial EA2222/PUMP, investigators are testing #PumpChemo in addition to SOC chemo versus SOC chemo alone for patients with unresectable #ColorectalCancer liver metastases. For more: https://t.co/xBChV6GALe cc: @michael_lidsky
0
4
8
Clinical study EA3191 is testing a new treatment approach for patients with squamous cell carcinoma of the head and neck (#HNSCC) that has come back after initial therapy. Learn more: https://t.co/0liEjdhnwI
#HeadAndNeckCancer #HNCA
0
0
0
In #ClinicalTrial EA7222, investigators are testing doxorubicin plus pembrolizumab vs. doxorubicin alone for patients with advanced undifferentiated pleomorphic sarcoma (UPS). For more information: https://t.co/KtdZ47T1GZ
#sarcomaawareness
0
0
0
#ClinicalTrial EA3211, led by @DavidSherMD of @utswcancer, aims to improve results for patients with #HeadAndNeckCancer that has spread to a limited number of places. Learn more: https://t.co/8vVaF19FDX
0
0
0
Do you have #PancreaticCancer with a BRCA1, BRCA2, or PALB2 mutation and resected (surgically removed) pancreatic cancer? If so, you may be able to participate in this study of a potential new treatment. Learn more: https://t.co/SjQfzYADSW cc: @KReissMD
1
3
4
You may be eligible to participate in a #prostatecancer study, EA8191/INDICATE, for patients with post-prostatectomy recurrence. Learn more: https://t.co/GG10ZcVkNj
#pcsm #ProstateCancerAware
0
0
0
Don't miss this special report, out today
Clinical trials remain out of reach for many Americans, with only 7% of patients with cancer participating in clinical trials, according to a new report from ASCO's State of Cancer Care in America series. Learn more: https://t.co/dZtYx4gQs5
@JCOOP_ASCO #ASCOQLTY25
0
0
2
Patients with aggressive B-cell #Lymphoma that has recurred or is resistant to treatment may be eligible to participate in #ClinicalTrial EA4231. Learn more here: https://t.co/hfbZzO89Q7 cc: @MelanicjMD, @theNCI, @UVACancerCenter
0
0
1
#Clinicaltrial EA8192 aims to find out if treatment with durvalumab and chemotherapy can improve outcomes for patients with high grade upper tract #urothelialcancer prior to nephroureterectomy. https://t.co/4dphxuN1s4
#blcsm #bladdercancer cc: @JCensits, @PGrivasMDPhD
0
2
3